Bank Of Montreal Zymeworks Inc. Transaction History

Bank Of Montreal

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$4.65 - $7.43 $62,096 - $99,220	13,354 Added 39.55%	47,120 $292,000
Q2 2022 Aug 11, 2022	BUY	$4.82 - $7.7 $42,869 - $68,483	8,894 Added 35.76%	33,766 $194,000
Q1 2022 May 12, 2022	BUY	$6.0 - $16.98 $24,618 - $69,668	4,103 Added 19.76%	24,872 $167,000
Q4 2021 Feb 11, 2022	BUY	$15.19 - $29.33 $106,816 - $206,248	7,032 Added 51.19%	20,769 $340,000
Q3 2021 Nov 12, 2021	BUY	$27.35 - $37.28 $16,929 - $23,076	619 Added 4.72%	13,737 $408,000
Q2 2021 Aug 12, 2021	BUY	$26.5 - $38.23 $347,627 - $501,501	13,118 New	13,118 $472,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $905M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.